Gene mutations that are thought to be very early events in the development of leukemias and other blood disorders appear to set the stage for malignancy by increasing the production of certain types of blood cells at the... Read more
The scope of the DNA changes that drive cancers has been illuminated as never before in a set of studies by a large international scientific team including Weill Cornell Medicine researchers. In six studies published Feb. 5... Read more
A change in the protein composition of chromatin—the condensed, packaged form of DNA in the nucleus—boosts the expression of metastasis-related genes; blocking this change appears to stop tumor cells from forming new tumors... Read more
Weill Cornell Medicine has received a prestigious Cancer Moonshot grant from the National Cancer Institute’s Immuno-Oncology Translational Network (IOTN) to explore the mechanisms that allow slow-growing lung cancer lesions... Read more
Dr. Silvia Formenti , chair of the Department of Radiation Oncology and the Sandra and Edward Meyer Professor of Cancer Research at Weill Cornell Medicine and radiation oncologist-in-chief at NewYork-Presbyterian/Weill... Read more
Dr. Silvia Formenti , chair of the Department of Radiation Oncology and the Sandra and Edward Meyer Professor of Cancer Research at Weill Cornell Medicine, and radiation oncologist-in-chief at NewYork-Presbyterian/Weill... Read more
Dr. Lewis Cantley , the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, has been awarded a grant from the Gray Foundation to study the genetic mutations that can lead to breast and... Read more
Dr. Gina Lee , a former postdoctoral fellow in the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine who has now joined the institution’s faculty, has won a 2019 Tri-Institutional Breakout Award for Junior... Read more
A powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables them to track the molecular evolution of cancers. The tools should enable a better... Read more
NewYork-Presbyterian's Health Matters' Amazing Things: Ronda Kotelchuck When Ronda Kotelchuck learned she had an aggressive form of uterine cancer, she was frightened and anxious about the road ahead. Within a week of her... Read more
Steven Lipkin, M.D., Ph.D., Co-Leader of the Meyer Cancer Center's Cancer Genetics, Epigenetics, and Systems Biology Program, reported results of a cancer prevention vaccine at the American Association for Cancer Research... Read more
Consuming the equivalent of one can of soda per day caused mice predisposed to colon cancer to develop larger tumors, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators. The study ,... Read more
Dr. Manuel Hidalgo, a leading physician-scientist who specializes in pancreatic cancer and drug development, has been named Chief of the Division of Hematology and Medical Oncology in the Weill Department of Medicine at... Read more
Early-career scientist Wendy Béguelin, PhD, has been named a NextGen Star by the American Association for Cancer Research (AACR). The AACR's NextGen Star Program provides an exciting opportunity to increase the visibility of... Read more
Ekta Khurana, Ph.D. , recently received the Irma T. Hirschl/Monique Weill-Caulier Scholar Award for her project, Using Chromatin Conformation Changes at Single-cell Level to Identify Drivers of Treatment Resistance in... Read more
Dr. Silvia Formenti, the Meyer Cancer Center's Associate Director of Radiation Oncology, and her collaborator Dr. Heather McArthur of Cedars Sinai have been awarded Stand Up To Cancer's 2019 Laura Ziskin Prize in... Read more
I have many fond memories of watching the soap opera General Hospital with my mom after school. The character of Dr. Lesley Webber became a role model for me. She always seemed sharp, focused, and capable no matter how much... Read more
This article first appeared on the WCM Newsroom . Researchers at Weill Cornell Medicine, in collaboration with investigators at Dana-Farber Cancer Institute , have been awarded a three-year, $1 million grant from the U.S... Read more
The Department of Radiation Oncology has been awarded two grants from the Department of Defense's Breast Cancer Program to study the combination of radiotherapy and immunotherapy in hormone receptor-positive breast cancer. A... Read more
The full article first appeared on the WCM Newsroom . Seven Weill Cornell Medicine faculty members leading multi-institutional research teams were awarded grants from The Starr Foundation's 12th Starr Cancer Consortium Grant... Read more
